Osimertinib (Tagrisso)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Osimertinib (Tagrisso), covering 2025-11-17 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer [Phase 1, Phase 2]